Photodynamic Therapy with Vertepofin for Short Time for Chronic Central Serous Chorioretinopathy
Journal of the Korean Ophthalmological Society
;
: 1078-1086, 2008.
Article
in Korean
| WPRIM
| ID: wpr-225348
ABSTRACT
PURPOSE:
To evaluate the clinical results of short duration photodynamic therapy (PDT) using verteporfin in patients with chronic central serous chorioretinopathy (CSC).METHODS:
We retrospectively examined 15 eyes after PDT for chronic central serous chorioretinopathy. PDT for 83 seconds was evaluated for 8 eyes, and PDT for 60 seconds was evaluated for 7 eyes. Improvement in vision and changes in central macular thickness were evaluated with an optical coherence tomogram (OCT), and improvement in leaking was evaluated with a fluorescein angiogram (FA). Recurrence was also studied.RESULTS:
Visual acuity improved from 0.39 to 0.57 (p=0.04), and the mean central macular thickness decreased from 426.29 micrometer to 184.71 micrometer (p<0.01) in 7 eyes treated with PDT for 60 seconds. There was no significant change in visual acuity between the two groups (p=0.77) or in central macular thickness (p=0.52). Central macular exudation resolved completely in all eyes. After PDT, there was no recurrence during the follow-up period.CONCLUSIONS:
Short duration PDT with verteporfin appears to be a beneficial treatment option for patients with chronic CSC.
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
Photochemotherapy
/
Porphyrins
/
Recurrence
/
Triazenes
/
Vision, Ocular
/
Visual Acuity
/
Retrospective Studies
/
Follow-Up Studies
/
Fluorescein
/
Tomography, Optical Coherence
Type of study:
Observational study
/
Prognostic study
Limits:
Humans
Language:
Korean
Journal:
Journal of the Korean Ophthalmological Society
Year:
2008
Type:
Article
Similar
MEDLINE
...
LILACS
LIS